Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$170.78 - $208.42 $15,540 - $18,966
91 Added 6.67%
1,455 $267,000
Q4 2023

Feb 05, 2024

SELL
$114.17 - $185.35 $15,527 - $25,207
-136 Reduced 9.07%
1,364 $245,000
Q3 2023

Nov 13, 2023

SELL
$138.78 - $176.51 $34,001 - $43,244
-245 Reduced 14.04%
1,500 $238,000
Q2 2023

Aug 10, 2023

SELL
$138.42 - $180.31 $31,144 - $40,569
-225 Reduced 11.42%
1,745 $246,000
Q1 2023

May 04, 2023

SELL
$154.26 - $198.1 $55,996 - $71,910
-363 Reduced 15.56%
1,970 $331,000
Q4 2022

Feb 10, 2023

SELL
$162.42 - $220.56 $23,388 - $31,760
-144 Reduced 5.81%
2,333 $395,000
Q3 2022

Nov 09, 2022

BUY
$160.42 - $256.21 $59,194 - $94,541
369 Added 17.5%
2,477 $464,000
Q2 2022

Aug 16, 2022

BUY
$140.68 - $188.02 $37,561 - $50,201
267 Added 14.5%
2,108 $342,000
Q1 2022

May 10, 2022

SELL
$161.19 - $257.96 $10,799 - $17,283
-67 Reduced 3.51%
1,841 $346,000
Q4 2021

Feb 03, 2022

BUY
$247.59 - $304.47 $16,340 - $20,095
66 Added 3.58%
1,908 $505,000
Q3 2021

Nov 04, 2021

SELL
$194.77 - $324.21 $15,971 - $26,585
-82 Reduced 4.26%
1,842 $532,000
Q2 2021

Aug 05, 2021

SELL
$165.87 - $220.95 $66,513 - $88,600
-401 Reduced 17.25%
1,924 $384,000
Q1 2021

Jun 02, 2021

BUY
$180.37 - $226.26 $14,068 - $17,648
78 Added 3.47%
2,325 $452,000
Q4 2020

Feb 10, 2021

SELL
$148.08 - $206.57 $14,363 - $20,037
-97 Reduced 4.14%
2,247 $431,000
Q3 2020

Nov 05, 2020

BUY
$122.51 - $158.27 $20,949 - $27,064
171 Added 7.87%
2,344 $346,000
Q2 2020

Aug 05, 2020

SELL
$94.33 - $140.48 $19,054 - $28,376
-202 Reduced 8.51%
2,173 $269,000
Q1 2020

May 06, 2020

BUY
$84.96 - $109.14 $201,779 - $259,207
2,375 New
2,375 $229,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.21B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Intrust Bank Na Portfolio

Follow Intrust Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.